PharmacoEconomics

The Doctor-Patient Relationship and Prescribing Patterns: A View from Primary Care
pp. 599-603(5)
Authors: Steinke D.T.; MacDonald T.M.; Davey P.G.

Measuring Quality of Life in Paediatric Patients
pp. 605-625(21)
Authors: Connolly M.A.; Johnson J.A.

Diagnosis and Management of Osteomyelitis: Decision Analytic and Pharmacoeconomic Considerations
pp. 627-647(21)
Authors: Tavakoli M.; Davey P.; Clift B.A.; Davies H.T.O.

Managing Pharmaceutical Expenditure while Increasing Access: The Pharmaceutical Management Agency (PHARMAC) Experience
pp. 649-660(12)
Authors: Braae R.; McNee W.; Moore D.

The Effect of Generic Competition on Prescription to Over-the-Counter Switching
pp. 661-668(8)
Author: Hollenbeak C.S.

Health Economics in the Canadian Pharmaceutical Industry
pp. 669-678(10)
Authors: Assiff L.; Pollock M.R.; Manzi P.; Faienza B.; Menon D.

Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis
pp. 679-697(19)
Authors: Goeree R.; O'Brien B.; Hunt R.; Blackhouse G.; Willan A.; Watson J.

Annual Cost of Erectile Dysfunction to UK Society
pp. 699-709(11)
Authors: Plumb J.M.; Guest J.F.

Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation
pp. 711-741(31)
Authors: Dunn C.J.; Foster R.H.

Acamprosate: Pharmacoeconomic Implications of Therapy
pp. 743-755(13)
Authors: Foster R.H.; McClellan K.J.